Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1400+0.0700 (+6.54%)
At close: 04:00PM EST
1.1400 0.00 (0.00%)
Pre-market: 05:13AM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts7677
Avg. Estimate-0.5-0.35-0.99-1.38
Low estimate-1-0.42-1.07-2
High estimate-0.33-0.18-0.9-0.9
Year ago EPS-0.54-0.57-2.31-0.99
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts6576
Avg. Estimate350k420k126.07M3.13M
Low estimateN/AN/A123.08MN/A
High estimate1.5M1.5M127.8M10M
Year ago sales1M1.38M7.13M126.07M
Sales growth (year/est)-65.20%-69.60%1,668.70%-97.50%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-0.46-0.550.53-0.5
Actual EPS-0.54-0.570.36-0.37
Difference-0.08-0.02-0.170.13
Surprise %-17.40%-3.60%-32.10%26.00%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate-0.5-0.35-0.99-1.38
7 days ago-0.5-0.37-0.99-1.37
30 days ago-0.5-0.37-0.99-1.36
60 days ago-0.49-0.36-0.98-1.32
90 days ago-0.49-0.36-0.98-1.32
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 days111N/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.7.40%N/AN/AN/A
Next qtr.38.60%N/AN/AN/A
Current year57.10%N/AN/AN/A
Next year-39.40%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A